Evidence map›Paper›PMID 17590405›Full record

ArticleVirology2007

Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.

Nia Tatsis, Shih-Wen Lin, Kimberly Harris-McCoy, David A Garber, Mark B Feinberg, Hildegund C J Ertl

Open access · greenAbstract read
In one paragraph

Article in Virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nia TatsisThe Wistar Institute, Philadelphia, PA, USA. tatsis@wistar.org
Shih-Wen Lin
Kimberly Harris-McCoy
David A Garber
Mark B Feinberg
Hildegund C J Ertl
The Wistar Institute · USEmory University · US

Funding

Project Coordination and Product DevelopmentU19AI061728 · NIAID · EMORY UNIVERSITY · PI ALTMAN, JOHN D · 2004 to 2008
$14.3M
Immune response to Adenoviral recombinants of ChimpanzeeP01AI052271 · NIAID · WISTAR INSTITUTE · PI ERTL, HILDEGUND C. J. · 2002 to 2006
$9.3M
NIAID NIH HHS P01 AI052271NIAID NIH HHS U19 AI061728NIAID NIH HHS U19 AI61728
6 · The paper itself

Abstract

Recombinant adenovirus vectors and MVA vectors were used in prime boost vaccine regimens to address the impact of repeated immunizations on transgene product-specific CD8(+) T cell frequencies, phenotypes, function, and localization. We show that a regimen with three immunizations incorporating MVA, human adenovirus serotype 5 and chimpanzee-derived adenoviruses serotype 68 or 7 yields high transgene product-specific CD8(+) T cell frequencies in spleen, blood, lymph nodes, and peritoneal lavage. Furthermore, upon triple immunization increased frequencies of transgene-specific T cells were measured at mucosal sites such as mesenteric lymph nodes, intestinal epithelium, and Peyer's patches. Multiple dose vaccine regimens that markedly increase functionally active transgene-specific T cells and target them to the appropriate ports of entry may be important in protection against pathogens such as HIV-1.

Indexed as

Genetic VectorsAdenoviridaeAIDS VaccinesAnimalsCD8-Positive T-LymphocytesFemaleGene Products, gagHIV-1HumansImmunizationImmunization ScheduleImmunization, SecondaryIntestinal MucosaLymph NodesLymphocyte ActivationMiceAIDS VaccinesGene Products, gag

Identifiers

PMID17590405
PMCPMC2043483
OpenAlexW2027915270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.